[Comparative study of the therapeutic activity of glutamic acid phthalimide and the therapeutic activity of triamcinolone in the treatment of Hansen's reaction of Virchowian Leprosy].
A study was made in twenty inpatients of the "Hospital das Clínicas" of the "Faculdade de Medicina da Universidade de São Paulo" in order to compare the short-term activities of the Brazilian made imidphtalic glutamic acid and of the triancinolone in the therapy of the hansenic reaction of the Virchowian hanseniasis (in the erythema nodosum and in the erythema multiform syndromes as well). In this research it was observed that the therapeutic activities of both drugs present a perfect and undeniable equivalence and that their use have reduced the period of hospitalization to 8,3 days per each patient.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*; D014221:Triamcinolone / Q000627:therapeutic use*
D014221:Triamcinolone; D013792:Thalidomide
Estudo comparativo entre a atividade terapêutica da imida ftálica do ácido glutâmico e a atividade terapêutica da triancinolona no tratamento da reação hansênica da hanseníase virchowiana.